127 related articles for article (PubMed ID: 26456648)
1. Activation and modulation of recombinantly expressed serotonin receptor type 3A by terpenes and pungent substances.
Ziemba PM; Schreiner BS; Flegel C; Herbrechter R; Stark TD; Hofmann T; Hatt H; Werner M; Gisselmann G
Biochem Biophys Res Commun; 2015 Nov; 467(4):1090-6. PubMed ID: 26456648
[TBL] [Abstract][Full Text] [Related]
2. Activation of human 5-hydroxytryptamine type 3 receptors via an allosteric transmembrane site.
Lansdell SJ; Sathyaprakash C; Doward A; Millar NS
Mol Pharmacol; 2015 Jan; 87(1):87-95. PubMed ID: 25338672
[TBL] [Abstract][Full Text] [Related]
3. Effect of ginseng saponins on the recombinant serotonin type 3A receptor expressed in xenopus oocytes: implication of possible application as an antiemetic.
Min KT; Koo BN; Kang JW; Bai SJ; Ko SR; Cho ZH
J Altern Complement Med; 2003 Aug; 9(4):505-10. PubMed ID: 14499026
[TBL] [Abstract][Full Text] [Related]
4. SR 57227A is a partial agonist/partial antagonist of 5-HT
Nakamura Y; Kondo M; Koyama Y; Shimada S
Biochem Biophys Res Commun; 2019 Jan; 508(2):590-596. PubMed ID: 30509492
[TBL] [Abstract][Full Text] [Related]
5. A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptors.
Thompson AJ; Lummis SC
Br J Pharmacol; 2013 Sep; 170(2):391-402. PubMed ID: 23822584
[TBL] [Abstract][Full Text] [Related]
6. Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide.
Michaelson SD; Paulsen IM; Kozuska JL; Martin IL; Dunn SM
Neuropharmacology; 2013 Oct; 73():398-403. PubMed ID: 23810831
[TBL] [Abstract][Full Text] [Related]
7. General anesthetic-induced channel gating enhancement of 5-hydroxytryptamine type 3 receptors depends on receptor subunit composition.
Solt K; Stevens RJ; Davies PA; Raines DE
J Pharmacol Exp Ther; 2005 Nov; 315(2):771-6. PubMed ID: 16081679
[TBL] [Abstract][Full Text] [Related]
8. Subunit-dependent inhibition and potentiation of 5-HT3 receptor by the anticancer drug, topotecan.
Nakamura Y; Ishida Y; Yamada T; Kondo M; Shimada S
J Neurochem; 2013 Apr; 125(1):7-15. PubMed ID: 23305320
[TBL] [Abstract][Full Text] [Related]
9. Direct interaction of the resistance to inhibitors of cholinesterase type 3 protein with the serotonin receptor type 3A intracellular domain.
Nishtala SN; Mnatsakanyan N; Pandhare A; Leung C; Jansen M
J Neurochem; 2016 May; 137(4):528-38. PubMed ID: 26875553
[TBL] [Abstract][Full Text] [Related]
10. Molecular properties important for inhaled anesthetic action on human 5-HT3A receptors.
Stevens RJN; Rüsch D; Davies PA; Raines DE
Anesth Analg; 2005 Jun; 100(6):1696-1703. PubMed ID: 15920198
[TBL] [Abstract][Full Text] [Related]
11. Subtle Differences among 5-HT
Price KL; Hirayama Y; Lummis SCR
ACS Chem Neurosci; 2017 May; 8(5):1085-1091. PubMed ID: 28367632
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a 5-HT
Price KL; Lummis SCR
ACS Chem Neurosci; 2018 Jun; 9(6):1409-1415. PubMed ID: 29508995
[TBL] [Abstract][Full Text] [Related]
13. Naturally occurring variations in the human 5-HT3A gene profoundly impact 5-HT3 receptor function and expression.
Krzywkowski K; Jensen AA; Connolly CN; Bräuner-Osborne H
Pharmacogenet Genomics; 2007 Apr; 17(4):255-66. PubMed ID: 17496724
[TBL] [Abstract][Full Text] [Related]
14. Yokukansan contains compounds that antagonize the 5-HT
Nakamura Y; Ishida Y; Kondo M; Shimada S
Phytomedicine; 2018 Apr; 43():120-125. PubMed ID: 29747744
[TBL] [Abstract][Full Text] [Related]
15. Orthosteric and Allosteric Activation of Human 5-HT
Rodriguez Araujo N; Fabiani C; Mazzarini Dimarco A; Bouzat C; Corradi J
Biophys J; 2020 Oct; 119(8):1670-1682. PubMed ID: 32946769
[TBL] [Abstract][Full Text] [Related]
16. The role of residues in binding loop A in desflurane and propofol modulation of recombinant 5-HT3A receptor.
Koo BN; Kim MK; Yang J; Min KT
Neurosci Lett; 2009 Nov; 465(2):147-50. PubMed ID: 19765401
[TBL] [Abstract][Full Text] [Related]
17. Which agonist properties are important for the activation of 5-HT3A receptors?
Meiboom MF; Barann M; Witten S; Groeneveld K; Urban BW
Biochim Biophys Acta; 2013 Nov; 1828(11):2564-73. PubMed ID: 23792067
[TBL] [Abstract][Full Text] [Related]
18. Effects of protostane-type triterpenoids on the 5-HT3A receptor-mediated ion current in Xenopus oocytes.
Lee JH; Lee YJ; Kang SW; Kim Y; Shin M; Hong M; Seo EK; Kim SH; Nah SY; Bae H
Brain Res; 2010 May; 1331():20-7. PubMed ID: 20307506
[TBL] [Abstract][Full Text] [Related]
19. The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors.
Pandhare A; Pappu AS; Wilms H; Blanton MP; Jansen M
Neuropharmacology; 2017 Feb; 113(Pt A):89-99. PubMed ID: 27671323
[TBL] [Abstract][Full Text] [Related]
20. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
